Welcome!

News Feed Item

Tic Disorder Global Clinical Trials Review, H2, 2014

NEW YORK, Aug. 11, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Tic Disorder Global Clinical Trials Review, H2, 2014

http://www.reportlinker.com/p02280950/Tic-Disorder-Global-Clinical-Trials-Review-H2-2014.html

Tic Disorder Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, "Tic Disorder Global Clinical Trials Review, H2, 2014" provides data on the Tic Disorder clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Tic Disorder. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Tic Disorder. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Tic Disorder 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Tic Disorder to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Tic Disorder to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Unaccomplished Trials of Tic Disorder 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Tic Disorder Therapeutics Clinical Trials 28
Prominent Drugs 29
Clinical Trial Profiles 30
Clinical Trial Overview of Top Companies 30
Otsuka Holdings Co., Ltd. 30
Clinical Trial Overview of Otsuka Holdings Co., Ltd. 30
Tasly Pharmaceuticals, Inc. 31
Clinical Trial Overview of Tasly Pharmaceuticals, Inc. 31
Clinical Trial Overview of Top Institutes / Government 32
National Institute of Neurological Disorders and Stroke 32
Clinical Trial Overview of National Institute of Neurological Disorders and Stroke 32
National Institute of Mental Health 33
Clinical Trial Overview of National Institute of Mental Health 33
Yale University 34
Clinical Trial Overview of Yale University 34
Parkinson's Disease and Movement Disorder Center of Boca Raton 35
Clinical Trial Overview of Parkinson's Disease and Movement Disorder Center of Boca Raton 35
Shiraz University of Medical Sciences 36
Clinical Trial Overview of Shiraz University of Medical Sciences 36
University of California, Los Angeles 37
Clinical Trial Overview of University of California, Los Angeles 37
New York University School of Medicine 38
Clinical Trial Overview of New York University School of Medicine 38
National Center for Research Resources 39
Clinical Trial Overview of National Center for Research Resources 39
Massachusetts General Hospital 40
Clinical Trial Overview of Massachusetts General Hospital 40
Washington University School of Medicine 41
Clinical Trial Overview of Washington University School of Medicine 41
Five Key Clinical Profiles 42
Appendix 67
Abbreviations 67
Definitions 67
Research Methodology 68
Secondary Research 68
About GlobalData 69
Contact Us 69
Disclaimer 69
Source 69

List of Tables

Tic Disorder Therapeutics, Global, Clinical Trials by Region, 2014* 7
Tic Disorder Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Tic Disorder Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Tic Disorder Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 10
Tic Disorder Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Tic Disorder Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Tic Disorder Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Tic Disorder Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Tic Disorder to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Tic Disorder Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Tic Disorder Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Tic Disorder to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Tic Disorder Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Tic Disorder Therapeutics, Global, Clinical Trials by Phase, 2014* 20
Tic Disorder Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 21
Tic Disorder Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
Tic Disorder Therapeutics Clinical Trials, Global, by End Point Status, 2014* 23
Tic Disorder Therapeutics, Global, Terminated Clinical Trials, 2014* 24
Tic Disorder Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25
Tic Disorder Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 26
Tic Disorder Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 27
Tic Disorder Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 28
Tic Disorder Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 29
Tic Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Otsuka Holdings Co., Ltd., 2014* 30
Tic Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Tasly Pharmaceuticals, Inc., 2014* 31
Tic Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Neurological Disorders and Stroke, 2014* 32
Tic Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Mental Health, 2014* 33
Tic Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Yale University, 2014* 34
Tic Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Parkinson's Disease and Movement Disorder Center of Boca Raton, 2014* 35
Tic Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Shiraz University of Medical Sciences, 2014* 36
Tic Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Los Angeles, 2014* 37
Tic Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by New York University School of Medicine, 2014* 38
Tic Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by National Center for Research Resources, 2014* 39
Tic Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2014* 40
Tic Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2014* 41

List of Figures

Tic Disorder Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Tic Disorder Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Tic Disorder Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Tic Disorder Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 10
Tic Disorder Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Tic Disorder Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Tic Disorder Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 14
Proportion of Tic Disorder to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Tic Disorder Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Tic Disorder Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Tic Disorder to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Tic Disorder Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Tic Disorder Therapeutics, Global, Clinical Trials by Phase (%), 2014* 20
Tic Disorder Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 21
Tic Disorder Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
Tic Disorder Therapeutics Clinical Trials, Global, by End Point Status, 2014* 23
Tic Disorder Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25
Tic Disorder Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 26
Tic Disorder Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 27
Tic Disorder Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 28
Tic Disorder Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 29
GlobalData Methodology 68


To order this report: Tic Disorder Global Clinical Trials Review, H2, 2014
http://www.reportlinker.com/p02280950/Tic-Disorder-Global-Clinical-Trials-Review-H2-2014.html



__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
In his session at @ThingsExpo, Sudarshan Krishnamurthi, a Senior Manager, Business Strategy, at Cisco Systems, will discuss how IT and operational technology (OT) work together, as opposed to being in separate siloes as once was traditional. Attendees will learn how to fully leverage the power of IoT in their organization by bringing the two sides together and bridging the communication gap. He will also look at what good leadership must entail in order to accomplish this, and how IT managers ca...
In his keynote at @ThingsExpo, Chris Matthieu, Director of IoT Engineering at Citrix and co-founder and CTO of Octoblu, focused on building an IoT platform and company. He provided a behind-the-scenes look at Octoblu’s platform, business, and pivots along the way (including the Citrix acquisition of Octoblu).
SYS-CON Events announced today that CA Technologies has been named “Platinum Sponsor” of SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY, and the 21st International Cloud Expo®, which will take place October 31-November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. CA Technologies helps customers succeed in a future where every business – from apparel to energy – is being rewritten by software. From ...
DevOps is being widely accepted (if not fully adopted) as essential in enterprise IT. But as Enterprise DevOps gains maturity, expands scope, and increases velocity, the need for data-driven decisions across teams becomes more acute. DevOps teams in any modern business must wrangle the ‘digital exhaust’ from the delivery toolchain, "pervasive" and "cognitive" computing, APIs and services, mobile devices and applications, the Internet of Things, and now even blockchain. In this power panel at @...
SYS-CON Events announced today that Outlyer, a monitoring service for DevOps and operations teams, has been named “Bronze Sponsor” of SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Outlyer is a monitoring service for DevOps and Operations teams running Cloud, SaaS, Microservices and IoT deployments. Designed for today's dynamic environments that need beyond cloud-scale monitoring, we make monitoring effortless so you...
Cloud Expo, Inc. has announced today that Andi Mann and Aruna Ravichandran have been named Co-Chairs of @DevOpsSummit at Cloud Expo 2017. The @DevOpsSummit at Cloud Expo New York will take place on June 6-8, 2017, at the Javits Center in New York City, New York, and @DevOpsSummit at Cloud Expo Silicon Valley will take place Oct. 31-Nov. 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
In his session at @ThingsExpo, Steve Wilkes, CTO and founder of Striim, will delve into four enterprise-scale, business-critical case studies where streaming analytics serves as the key to enabling real-time data integration and right-time insights in hybrid cloud, IoT, and fog computing environments. As part of this discussion, he will also present a demo based on its partnership with Fujitsu, highlighting their technologies in a healthcare IoT use-case. The demo showcases the tracking of pati...
With 10 simultaneous tracks, keynotes, general sessions and targeted breakout classes, Cloud Expo and @ThingsExpo are two of the most important technology events of the year. Since its launch over eight years ago, Cloud Expo and @ThingsExpo have presented a rock star faculty as well as showcased hundreds of sponsors and exhibitors! In this blog post, I provide 7 tips on how, as part of our world-class faculty, you can deliver one of the most popular sessions at our events. But before reading the...
In his keynote at 18th Cloud Expo, Andrew Keys, Co-Founder of ConsenSys Enterprise, provided an overview of the evolution of the Internet and the Database and the future of their combination – the Blockchain. Andrew Keys is Co-Founder of ConsenSys Enterprise. He comes to ConsenSys Enterprise with capital markets, technology and entrepreneurial experience. Previously, he worked for UBS investment bank in equities analysis. Later, he was responsible for the creation and distribution of life settle...
A strange thing is happening along the way to the Internet of Things, namely far too many devices to work with and manage. It has become clear that we'll need much higher efficiency user experiences that can allow us to more easily and scalably work with the thousands of devices that will soon be in each of our lives. Enter the conversational interface revolution, combining bots we can literally talk with, gesture to, and even direct with our thoughts, with embedded artificial intelligence, whic...
SYS-CON Events announced today that Cloud Academy will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Cloud Academy is the industry’s most innovative, vendor-neutral cloud technology training platform. Cloud Academy provides continuous learning solutions for individuals and enterprise teams for Amazon Web Services, Microsoft Azure, Google Cloud Platform, and the most popular cloud computing technologies. Ge...
The best way to leverage your Cloud Expo presence as a sponsor and exhibitor is to plan your news announcements around our events. The press covering Cloud Expo and @ThingsExpo will have access to these releases and will amplify your news announcements. More than two dozen Cloud companies either set deals at our shows or have announced their mergers and acquisitions at Cloud Expo. Product announcements during our show provide your company with the most reach through our targeted audiences.
DevOps is being widely accepted (if not fully adopted) as essential in enterprise IT. But as Enterprise DevOps gains maturity, expands scope, and increases velocity, the need for data-driven decisions across teams becomes more acute. DevOps teams in any modern business must wrangle the ‘digital exhaust’ from the delivery toolchain, "pervasive" and "cognitive" computing, APIs and services, mobile devices and applications, the Internet of Things, and now even blockchain.
WebRTC is the future of browser-to-browser communications, and continues to make inroads into the traditional, difficult, plug-in web communications world. The 6th WebRTC Summit continues our tradition of delivering the latest and greatest presentations within the world of WebRTC. Topics include voice calling, video chat, P2P file sharing, and use cases that have already leveraged the power and convenience of WebRTC.
In his general session at 18th Cloud Expo, Lee Atchison, Principal Cloud Architect and Advocate at New Relic, discussed cloud as a ‘better data center’ and how it adds new capacity (faster) and improves application availability (redundancy). The cloud is a ‘Dynamic Tool for Dynamic Apps’ and resource allocation is an integral part of your application architecture, so use only the resources you need and allocate /de-allocate resources on the fly.